- Home
- CRMD vs NCMI Comparison
CRMD vs NCMI Comparison
Compare CRMD & NCMI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRMD
- NCMI
- Stock Information
- Founded
- CRMD 2006
- NCMI 2005
- Country
- CRMD United States
- NCMI United States
- Employees
- CRMD N/A
- NCMI N/A
- Industry
- CRMD Biotechnology: Pharmaceutical Preparations
- NCMI Advertising
- Sector
- CRMD Health Care
- NCMI Consumer Discretionary
- Exchange
- CRMD Nasdaq
- NCMI Nasdaq
- Market Cap
- CRMD 464.7M
- NCMI N/A
- IPO Year
- CRMD 2010
- NCMI 2007
- Fundamental
- Price
- CRMD $12.03
- NCMI $4.95
- Analyst Decision
- CRMD Strong Buy
- NCMI Strong Buy
- Analyst Count
- CRMD 6
- NCMI 5
- Target Price
- CRMD $15.00
- NCMI $7.60
- AVG Volume (30 Days)
- CRMD 2.1M
- NCMI 851.7K
- Earning Date
- CRMD 05-06-2025
- NCMI 05-06-2025
- Dividend Yield
- CRMD N/A
- NCMI 0.60%
- EPS Growth
- CRMD N/A
- NCMI N/A
- EPS
- CRMD 0.28
- NCMI N/A
- Revenue
- CRMD $82,553,827.00
- NCMI $238,300,000.00
- Revenue This Year
- CRMD $207.65
- NCMI $15.11
- Revenue Next Year
- CRMD $50.13
- NCMI $9.16
- P/E Ratio
- CRMD $43.34
- NCMI N/A
- Revenue Growth
- CRMD N/A
- NCMI 42.10
- 52 Week Low
- CRMD $3.61
- NCMI $4.12
- 52 Week High
- CRMD $13.85
- NCMI $7.60
- Technical
- Relative Strength Index (RSI)
- CRMD 76.78
- NCMI 30.40
- Support Level
- CRMD $8.72
- NCMI $4.12
- Resistance Level
- CRMD $9.82
- NCMI $5.88
- Average True Range (ATR)
- CRMD 0.65
- NCMI 0.31
- MACD
- CRMD 0.42
- NCMI -0.07
- Stochastic Oscillator
- CRMD 94.49
- NCMI 40.29
About CRMD CorMedix Inc.
Cormedix Inc is a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions. The Company's focus is on the commercialization of its product, DefenCath, in the United States (U.S.) and other key markets. The group currently operates in a single segment, Drug Product, located in a single geographic location, the United States.